Stockscreener 앱 받기
0.00
100.00%
-8.28
시간 외 거래:
8.45
8.45
+
Cybin Inc 주식(CYBN)의 최신 뉴스
Helus Pharma reports encouraging Phase 2 results for HLP004 anxiety treatment - MSN
Top Cybin (HELP) Competitors 2026 - MarketBeat
Point72 / Cohen disclose 686,669 shares in Cybin (CYBN) - Stock Titan
Sirenia (CYBN) discloses 3,677,966 shares; 7.2% stake including warrants - Stock Titan
Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research - MSN
Cybin (HELP) Institutional Ownership 2026 $HELP - MarketBeat
Number of shareholders of Cybin Inc. – NASDAQ:HELP - TradingView
BetterLife Pharma Announces Appointment of Doug Drysdale as Executive Chairman and Director - The Globe and Mail
Helus Pharma propels therapeutic innovation in mental health and commences trading on Nasdaq - MSN
TradingKey - TradingKey
EDGAR Filing Documents for 0001628280-25-033606 - SEC.gov
symbol__ Stock Quote Price and Forecast - CNN
Cybin Inc. (NASDAQ:HELP) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
HELP Technical Analysis & Stock Price Forecast - Intellectia AI
Cybin (NASDAQ:HELP) Shares Up 2.7%Should You Buy? - MarketBeat
Helus Pharma Partners With TARA Mind to Boost Phase 3 Depression Trial in Veterans After U.S. Executive Order - TipRanks
Helus Pharma (Nasdaq: HELP) partners with TARA Mind to boost veteran trial access - Stock Titan
CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - Investing News Network
Cybin Inc. will Change its Name to Helus Pharma - marketscreener.com
Helus Pharma CEO to Spotlight Mental Health Innovation at 29th Milken Global Conference - TipRanks
Helus Pharma (CYBN) interim CEO to join Milken Global Conference health innovation panel - Stock Titan
Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference - The Manila Times
A Milken health-innovation panel will feature Helus Pharma's interim CEO - Stock Titan
Helus turns to TARA Mind to reach veterans for depression trial - Stock Titan
MSN Money - MSN
Helus Pharma Partners With TARA Mind to Boost Phase 3 Trial Recruitment for Major Depressive Disorder in Veterans - MEXC
Helus Pharma Aligns With U.S. Veteran Mental Health Push in New TARA Mind Partnership - TipRanks
Cybin (CYBN) Helus Pharma joins TARA Mind to boost HLP003 Phase 3 veteran trial - Stock Titan
Cybin to move US stock listing to Nasdaq from NYSE American - MSN
Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - Investing News Network
Helus Pharma partners with TARA Mind for trial recruitment - Investing.com
Helus Pharma partners with TARA Mind for trial recruitment By Investing.com - Investing.com UK
HELP | Cybin Inc. Common Stock Insider Trading - Quiver Quantitative
Cybin initiates at-the-market equity program of up to $100 million - MSN
Biggest stock movers Wednesday: Vanda Pharmaceuticals, Axsome Therapeutics and Cybin - MSN
Helus Pharma CEO Michael Cola steps down; Eric So takes interim CEO role - MSN
Does Robert Langer’s Arrival Reframe Confidence in Cybin’s (HELP) Clinical Strategy and Execution Risk? - Yahoo Finance
0.71%
자본화:
|
볼륨(24시간):